Insights into mucosal-associated invariant T cell biology from studies of invariant natural killer T cells by Garner, L, Klenerman, P, Provine, N

There’s more to reflectance spectroscopy than lux by Beeby, A, Garner, L, Howell, D, Nicholson, C

CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action by Garner, L, Hartland, A, Breuning, J, Brown, M

Fine specificity and molecular competition in SLAM family receptor signalling by Wilson, T, Garner, L, Metcalfe, C, King, E, Margraf, S, Brown, M

Expression of lectin-like transcript-1 in human tissues by Llibre, A, Garner, L, Partridge, A, Freeman, GJ, Klenerman, P, Willberg, CB

Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility com... by Antrobus, R, Khan, N, Hislop, A, Montamat-Sicotte, D, Garner, L, Rickinson, AB, Moss, P, Willcox, B

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation by Huisman, BD, Guan, N, Rückert, T, Garner, L, Singh, NK, McMichael, AJ, Gillespie, GM, Romagnani, C, Birnbaum, ME

Unique and common features of innate-like human Vδ2+ γδT cells and mucosal-associated invariant T cells by Provine, N, Binder, B, FitzPatrick, M, Schuch, A, Garner, L, Williamson, K, van Wilgenburg, B, Thimme, R, Klenerman, P, Hofmann, M

Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist. by Frago, S, Nicholls, R, Strickland, M, Hughes, J, Williams, C, Garner, L, Surakhy, M, Maclean, R, Rezgui, D, Prince, S, Zaccheo, O, Ebner, D, Sanegre, S, Yu, S, Buffa, F, Crump, M, Hassan, A

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses by Lin, Z, Bashirova, AA, Viard, M, Garner, L, Quastel, M, Beiersdorfer, M, Kasprzak, WK, Akdag, M, Yuki, Y, Ojeda, P, Das, S, Andresson, T, Naranbhai, V, Horowitz, A, McMichael, AJ, Hoelzemer, A, Gillespie, GM, Garcia-Beltran, WF, Carrington, M

MAIT cell activation augments adenovirus vector vaccine immunogenicity by Provine, N, Amini, A, Garner, L, Spencer, A, Dold, C, Hutchings, C, Silva Reyes, L, Fitzpatrick, M, Chinnakannan, S, Oguti, B, Raymond, M, Ulaszewska, M, Troise, F, Sharpe, H, Morgan, S, Hinks, T, Lambe, T, Capone, S, Folgori, A, Barnes, E, Rollier, C, Pollard, A, Klenerman, P

HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation by Yang, H, Sun, H, Brackenridge, S, Zhuang, X, Wing, PAC, Quastel, M, Walters, L, Garner, L, Wang, B, Yao, X, Felce, SL, Peng, Y, Moore, S, Peeters, BWA, Rei, M, Canto Gomes, J, Tomas, A, Davidson, A, Semple, MG, Turtle, LCW, Openshaw, PJM, Baillie, JK, Mentzer, AJ, Klenerman, P, ISARIC4C Investigators, Borrow, P, Dong, T, McKeating, JA, Gillespie, GM, McMichael, AJ